Randomized Trial on the Clinical Utility of a Novel Biomarker Panel to Identify Treatable Determinants of Chronic Pain
Millions suffer daily from chronic pain diagnosed anatomically and treated with opioids. Research shows that underlying nutritional, metabolic and oxidative stressors, which drive the development or worsening of chronic pain, are not diagnosed despite the fact that treatment of these primary pain pa...
Main Authors: | John Peabody, David Paculdo, Diana Tamondong-Lachica, Ian Theodore Cabaluna, Joshua Gunn |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/10/8/513 |
Similar Items
-
A rare but treatable cause of recurrent chest pain - Ictal chest pain
by: Ching Soong Khoo, et al.
Published: (2019-12-01) -
Clinical Validation of a Multi-Biomarker Assay for the Evaluation of Chronic Pain Patients in a Cross-Sectional, Observational Study
by: Kasra Amirdelfan, et al.
Published: (2020-06-01) -
Pain Acceptance and Pain-Related Disability Predict Healthcare Utilization and Medication Intake in Patients with Non-Specific Chronic Spinal Pain
by: Rosa Esteve, et al.
Published: (2020-07-01) -
Impact of a multidisciplinary pain management program on patient care utilization and cost of care
by: Maeng DD, et al.
Published: (2018-10-01) -
Beta Electroencephalographic Oscillation Is a Potential GABAergic Biomarker of Chronic Peripheral Neuropathic Pain
by: Micael Teixeira, et al.
Published: (2021-02-01)